SARS-CoV-2 Detection in Gingival Crevicular Fluid

被引:87
|
作者
Gupta, S. [1 ]
Mohindra, R. [2 ]
Chauhan, P. K. [3 ]
Singla, V. [2 ]
Goyal, K. [3 ]
Sahni, V. [4 ]
Gaur, R. [3 ]
Verma, D. K. [3 ]
Ghosh, A. [3 ]
Soni, R. K. [2 ]
Suri, V. [2 ]
Bhalla, A. [2 ]
Singh, M. P. [3 ]
机构
[1] Post Grad Inst Med Educ & Res PGIMER, Oral Hlth Sci Ctr, Unit Periodont, Chandigarh, India
[2] PGIMER, Dept Internal Med, Chandigarh, India
[3] PGIMER, Dept Virol, Sect 12, Chandigarh 160012, India
[4] Panjab Univ, Dr Harvansh Singh Judge Inst Dent Sci & Hosp, Chandigarh, India
关键词
COVID-19; oral health; oral hygiene; saliva; diagnostics; periodontal; SALIVA;
D O I
10.1177/0022034520970536
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Understanding the pathophysiology of the coronavirus disease 2019 (COVID-19) infection remains a significant challenge of our times. The gingival crevicular fluid being representative of systemic status and having a proven track record of detecting viruses and biomarkers forms a logical basis for evaluating the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study aimed to assess gingival crevicular fluid (GCF) for evidence of SARS-CoV-2 in 33 patients who were deemed to be COVID-19 positive upon nasopharyngeal sampling. An attempt was also made to comparatively evaluate it with saliva in terms of its sensitivity, as a diagnostic fluid for SARS-CoV-2. GCF and saliva samples were collected from 33 COVID-19-confirmed patients. Total RNA was extracted using NucliSENS easyMAG (bioMerieux) and eluted in the elution buffer. Envelope gene (E gene) of SARS-CoV-2 and human RNase P gene as internal control were detected in GCF samples by using the TRUPCR SARS-CoV-2 RT qPCR kit V-2.0 (I) in an Applied Biosystems 7500 real-time machine. A significant majority of both asymptomatic and mildly symptomatic patients exhibited the presence of the novel coronavirus in their GCF samples. Considering the presence of SARS-CoV-2 RNA in the nasopharyngeal swab sampling as gold standard, the sensitivity of GCF and saliva, respectively, was 63.64% (confidence interval [CI], 45.1% to 79.60%) and 64.52% (CI, 45.37% to 80.77%). GCF was found to be comparable to saliva in terms of its sensitivity to detect SARS-CoV-2. Saliva samples tested positive in 3 of the 12 patients whose GCF tested negative, and likewise GCF tested positive for 2 of the 11 patients whose saliva tested negative on real-time reverse transcription polymerase chain reaction. The results establish GCF as a possible mode of transmission of SARS-CoV-2, which is the first such report in the literature, and also provide the first quantifiable evidence pointing toward a link between the COVID-19 infection and oral health.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 50 条
  • [31] Comparison of SARS-CoV-2 Detection from Saliva Sampling and Oropharyngeal Swab
    Clemmensen, Mia de Laurent
    Bendixen, Kamilla Kolding
    Flugt, Katharina
    Pilgaard, Pernille
    Christensen, Ulf Bech
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [32] Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients
    Kandel, Christopher
    Zheng, Jennifer
    McCready, Janine
    Serbanescu, Mihaela Anca
    Racher, Hilary
    Desaulnier, Melissa
    Powis, Jeff E.
    Vojdani, Kyle
    Finlay, Laura
    Sheldrake, Elena
    Vermeiren, Christie
    Katz, Kevin
    McGeer, Allison
    Kozak, Robert
    Goneau, Lee W.
    VIRUSES-BASEL, 2020, 12 (11):
  • [33] Saliva Is a Promising Alternative Specimen for the Detection of SARS-CoV-2 in Children and Adults
    Yee, Rebecca
    Truong, Thao
    Pannaraj, Pia S.
    Eubanks, Natalie
    Gai, Emily
    Jumarang, Jaycee
    Turner, Lauren
    Peralta, Ariana
    Lee, Yesun
    Bard, Jennifer Dien
    JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (02)
  • [34] Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients
    Tutuncu, Emin Ediz
    Ozgur, Didem
    Karamese, Murat
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 2932 - 2937
  • [35] SARS-CoV-2 antigen rapid tests For reliable detection of SARS-CoV-2 infection not suitable
    Reuter, Tom
    Lange, Constanze
    Zeyher, Sharay
    Woelk, Benno
    Kramer, Jan
    PRAVENTION UND GESUNDHEITSFORDERUNG, 2023, 18 (03): : 370 - 376
  • [36] Portable microfluidic impedance biosensor for SARS-CoV-2 detection
    Laleh, Soroush
    Ibarlucea, Bergoi
    Stadtmueller, Marlena
    Cuniberti, Gianaurelio
    Medina-Sanchez, Mariana
    BIOSENSORS & BIOELECTRONICS, 2023, 236
  • [37] Rapid SARS-CoV-2 Detection Using Electrochemical Immunosensor
    Mojsoska, Biljana
    Larsen, Sylvester
    Olsen, Dorte Aalund
    Madsen, Jonna Skov
    Brandslund, Ivan
    Alatraktchi, Fatima AlZahra'a
    SENSORS, 2021, 21 (02) : 1 - 11
  • [38] Methods of SARS-CoV-2 detection in tissue
    von Stillfried, Saskia
    Boor, Peter
    PATHOLOGE, 2021, 42 (02): : 208 - 215
  • [39] Detection of SARS-CoV-2 in ophthalmic secretions
    Arshad, Yasir
    Mahmood, Nayab
    Zaidi, Syed Sohail Zahoor
    Sharif, Salmaan
    Ikram, Aamer
    Alam, Muhammad Masroor
    Ali, Muhammad Qaisar
    Usman, Muhammad
    Akhtar, Ribqa
    Hassan, Muhammad
    Salman, Muhammad
    Adil, Naveed
    Rana, Muhammad Suleman
    JOURNAL OF INFECTION, 2021, 82 (02) : E25 - E26
  • [40] Detection of SARS-CoV-2 at the point of care
    Loeffelholz, Michael J.
    Tang, Yi-Wei
    BIOANALYSIS, 2021, 13 (15) : 1213 - 1223